Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
64%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
OZEM
19
HOLDINGS
83%
ALSO IN THNR
THNR
18
HOLDINGS
83%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 18.4% | 15.8% | 15.8% |
 |
NOVO-NORDISK A/S-SPONS ADR | 14.2% | 10.7% | 10.7% |
 |
ROCHE HOLDING LTD | 5.4% | 5.4% | 5.4% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 5.1% | 7.5% | 5.1% |
|
PFIZER INC | 3.6% | 4.8% | 3.6% |
OZEM Overweight Relative to THNR
|
VIKING THERAPEUTICS, INC. | 5.8% |
|
NOVO-NORDISK A/S-SPONS ADR | 3.4% |
|
ELI LILLY & CO | 2.7% |
|
ZEALAND PHARMA A/S | 2.0% |
 |
HANMI PHARM CO LTD | 1.9% |
|
RHYTHM PHARMACEUTICALS, INC. | 1.9% |
|
GILEAD SCIENCES INC | 1.7% |
|
SCHOLAR ROCK HOLDING CORP. | 0.8% |
 |
THE UNITED LABORATORIES INTE | 0.5% |
|
ROCHE HOLDING LTD | 0.0% |
OZEM Underweight Relative to THNR
|
MERCK & CO. INC. | -5.5% |
|
REGENERON PHARMACEUTICALS | -4.7% |
|
ABBVIE INC | -4.7% |
|
AMGEN INC | -3.4% |
|
HIMS & HERS HEALTH, INC. CLASS A | -3.3% |
|
SHIONOGI & CO LTD | -3.1% |
|
CHUGAI PHARMACEUTICAL CO LTD | -2.4% |
|
CHINA PHARMACEUTICAL GROUP | -2.2% |
 |
ASTRAZENECA PLC-SPONS ADR | -1.5% |
|
PFIZER INC | -1.2% |